NICE proposes to withdraw Alzheimer's drugs from NHS.
Kmietowicz
Zosia
Z
D000544:Alzheimer Disease / Q000188:drug therapy*; D002800:Cholinesterase Inhibitors / Q000600:supply & distribution / Q000627:therapeutic use; D003362:Cost-Benefit Analysis; D000077265:Donepezil; D016527:Drug Costs; D004739:England; D005569:Formularies as Topic; D006801:Humans; D007189:Indans / Q000600:supply & distribution / Q000627:therapeutic use; D008559:Memantine / Q000600:supply & distribution / Q000627:therapeutic use; D048448:Phenylcarbamates / Q000600:supply & distribution / Q000627:therapeutic use; D010880:Piperidines / Q000600:supply & distribution / Q000627:therapeutic use; D017410:Practice Guidelines as Topic; D000068836:Rivastigmine; D013222:State Medicine; D014852:Wales
D002800:Cholinesterase Inhibitors; D007189:Indans; D048448:Phenylcarbamates; D010880:Piperidines; D000077265:Donepezil; D000068836:Rivastigmine; D008559:Memantine